CA1075605A - Infusion solutions with salts of glycerophosphates - Google Patents

Infusion solutions with salts of glycerophosphates

Info

Publication number
CA1075605A
CA1075605A CA238,444A CA238444A CA1075605A CA 1075605 A CA1075605 A CA 1075605A CA 238444 A CA238444 A CA 238444A CA 1075605 A CA1075605 A CA 1075605A
Authority
CA
Canada
Prior art keywords
solution
glycerophosphate
phosphorus
sodium
phosphate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA238,444A
Other languages
English (en)
French (fr)
Inventor
Werner Fekl
Helmut Mader
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Health AB
Original Assignee
Kabi Pharmacia AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kabi Pharmacia AB filed Critical Kabi Pharmacia AB
Application granted granted Critical
Publication of CA1075605A publication Critical patent/CA1075605A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/30Zinc; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/14Alkali metal chlorides; Alkaline earth metal chlorides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CA238,444A 1975-01-23 1975-10-22 Infusion solutions with salts of glycerophosphates Expired CA1075605A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2502735A DE2502735B2 (de) 1975-01-23 1975-01-23 Verwendung von Glycerophosphaten

Publications (1)

Publication Number Publication Date
CA1075605A true CA1075605A (en) 1980-04-15

Family

ID=5937143

Family Applications (1)

Application Number Title Priority Date Filing Date
CA238,444A Expired CA1075605A (en) 1975-01-23 1975-10-22 Infusion solutions with salts of glycerophosphates

Country Status (4)

Country Link
CA (1) CA1075605A (de)
DE (1) DE2502735B2 (de)
GB (1) GB1516738A (de)
ZA (1) ZA755795B (de)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8431086B2 (en) 2006-07-20 2013-04-30 Baxter International Inc. Medical fluid access device with antiseptic indicator
US8485727B2 (en) 2005-08-02 2013-07-16 Baxter International Inc. Multiple chamber container

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5916818A (ja) * 1982-07-20 1984-01-28 Shimizu Seiyaku Kk 経静脈投与用輸液剤
SE8701662L (sv) * 1987-04-22 1988-10-23 Gelder Nico M Van Saett och medel foer att behandla neurologiska sjukdomar, exempelvis migraen genom paaverkan av nervcellerna
US6537969B1 (en) * 1997-10-24 2003-03-25 John P. Blass Nutritional supplement for cerebral metabolic insufficiencies
GB2544782B (en) * 2015-11-26 2020-07-15 Fontus Health Ltd Solution

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8485727B2 (en) 2005-08-02 2013-07-16 Baxter International Inc. Multiple chamber container
US8431086B2 (en) 2006-07-20 2013-04-30 Baxter International Inc. Medical fluid access device with antiseptic indicator

Also Published As

Publication number Publication date
DE2502735A1 (de) 1976-08-05
AU8450175A (en) 1977-03-10
ZA755795B (en) 1976-09-29
GB1516738A (en) 1978-07-05
DE2502735B2 (de) 1978-11-23

Similar Documents

Publication Publication Date Title
US5210083A (en) Pharmaceutical compositions
US4320146A (en) Treatment of hepatic and renal disorders with ornithine and arginine salts of branched chain keto acids
US4228099A (en) Ornithine and arginine salts of branched chain keto acids and uses in treatment of hepatic and renal disorders
Schachter et al. Treatment of oligospermia with the amino acid arginine
US4604286A (en) Infusion solution for parenteral nutrition
US5719119A (en) Parenteral nutrition therapy with amino acids
US4814326A (en) Pharmaceutical compositions based on diphosphonates for the treatment of arthrosis and osteoarthritis
DE2260189A1 (de) Injizierbare aminosaeurepraeparate
JPH05163139A (ja) 抗動脈硬化剤
CA1075605A (en) Infusion solutions with salts of glycerophosphates
WO1987003806A1 (en) Parenteral nutrition therapy with amino acids
US4185093A (en) Preparation and method for treatment of hypocalcemia, hypophosphatemia and downer cow syndrome in animals
EP0136463B1 (de) Injizierbare pharmazeutische Zusammenstellungen die beständige 5-Adenosyl-L-Methionin-Salze enthalten
Kidder et al. Studies on the inorganic requirements of Tetrahymena
JP3182564B2 (ja) 栄養組成物
EP0288907A3 (de) Methode gegen den Verlust der wahrnehmenden Funktionen unter Einsatz von ACE-Hemmern
GB2094142A (en) Injectable solution containing theophylline and a basic amino acid
CA1103160A (en) Infusion solution for the treatment of hepatic encephalopathy and method of using them
Eaton et al. Inhibition of influenza and mumps viruses in tissue culture by basic amino acids.
US5348749A (en) Method for treating panic disorder
IT8319024A1 (it) Composizione medicinale per il trattamento di certe neurovirosi
IE66515B1 (en) Stable solutions of rebeccamycin analog and preparation thereof
JP2720165B2 (ja) ぶどう糖電解質配合剤
ATE378045T1 (de) VERWENDUNG DES PHARMAZEUTISCHEN PRÄPARATES ßHISTOCHROMEß ZUR BEHANDLUNG DES AKUTEN HERZINFARKTS UND ISCHÄMISCHER HERZERKRANKUNGEN
US2803657A (en) Acid stabilized tetracycline salts

Legal Events

Date Code Title Description
MKEX Expiry